Mechanisms of Vascular Aging, A Geroscience Perspective: JACC Focus Seminar.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
03 03 2020
Historique:
received: 08 10 2019
revised: 15 11 2019
accepted: 19 11 2019
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Age-related pathological alterations of the vasculature have a critical role in morbidity and mortality of older adults. In epidemiological studies, age is the single most important cardiovascular risk factor that dwarfs the impact of traditional risk factors. To develop novel therapeutic interventions for prevention of age-related vascular pathologies, it is crucial to understand the cellular and molecular mechanisms of vascular aging. In this review, shared molecular mechanisms of aging are considered in terms of their contribution to the pathogenesis of macrovascular and microvascular diseases associated with old age. The role of cellular senescence in development of vascular aging phenotypes is highlighted, and potential interventions to prevent senescence and to eliminate senescent cells for prevention of vascular pathologies are presented. The evidence supporting a role for interorgan communication and circulating progeronic and antigeronic factors in vascular aging is discussed.

Identifiants

pubmed: 32130929
pii: S0735-1097(20)30068-1
doi: 10.1016/j.jacc.2019.11.061
pmc: PMC8559983
mid: NIHMS1569132
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

931-941

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM125528
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG052363
Pays : United States

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

Aging Cell. 2015 Jun;14(3):400-8
pubmed: 25677910
Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H363-72
pubmed: 21602469
Diabetes Care. 2019 Oct;42(10):1946-1955
pubmed: 30796109
Br J Pharmacol. 2002 Mar;135(6):1347-50
pubmed: 11906946
J Gerontol A Biol Sci Med Sci. 2013 Dec;68(12):1443-57
pubmed: 23689827
Aging Cell. 2016 Oct;15(5):973-7
pubmed: 26864908
Hypertension. 2018 Jun;71(6):1056-1063
pubmed: 29661838
Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H693-H703
pubmed: 29351469
Nat Med. 2018 Aug;24(8):1246-1256
pubmed: 29988130
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1963-74
pubmed: 26139463
J Clin Invest. 2013 Mar;123(3):966-72
pubmed: 23454759
Mutat Res. 2005 Feb 15;570(1):81-8
pubmed: 15680405
Redox Biol. 2019 Jun;24:101192
pubmed: 31015147
Circ Res. 2016 Aug 5;119(4):564-71
pubmed: 27267067
Circ Res. 2018 Sep 14;123(7):849-867
pubmed: 30355080
Science. 2016 Oct 28;354(6311):472-477
pubmed: 27789842
J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):200-3
pubmed: 18314458
Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H890-H895
pubmed: 28971843
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Nature. 2011 Nov 02;479(7372):232-6
pubmed: 22048312
J Cereb Blood Flow Metab. 2013 Sep;33(9):1412-21
pubmed: 23801246
Am J Physiol Heart Circ Physiol. 2013 Jul 15;305(2):H251-8
pubmed: 23666675
Antioxid Redox Signal. 2014 Dec 10;21(17):2344-63
pubmed: 24506455
Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1253-H1266
pubmed: 30875255
Geroscience. 2017 Feb;39(1):33-42
pubmed: 28299642
Cell Metab. 2008 Aug;8(2):157-68
pubmed: 18599363
Stroke. 2016 Apr;47(4):1068-77
pubmed: 26883501
Atherosclerosis. 2015 Jul;241(1):121-9
pubmed: 25974102
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H37-47
pubmed: 17416599
Circulation. 2013 Aug 13;128(7):702-12
pubmed: 23841983
Biochem Biophys Res Commun. 2015 Oct 2;465(4):732-8
pubmed: 26296466
Circulation. 2012 Jul 24;126(4):468-78
pubmed: 22705887
Circulation. 2003 Aug 12;108(6):678-83
pubmed: 12900349
Nat Rev Cardiol. 2018 Sep;15(9):555-565
pubmed: 29795441
Circ Res. 2015 Feb 27;116(5):816-26
pubmed: 25524056
J Gerontol A Biol Sci Med Sci. 2013 Mar;68(3):235-49
pubmed: 22904098
J Am Heart Assoc. 2018 Sep 18;7(18):e009112
pubmed: 30371211
Geroscience. 2018 Dec;40(5-6):513-521
pubmed: 30470983
Circ Res. 2016 May 13;118(10):1626-42
pubmed: 27174954
Circulation. 2003 Jan 7;107(1):139-46
pubmed: 12515756
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3587-92
pubmed: 18305170
Mech Ageing Dev. 2009 Aug;130(8):518-27
pubmed: 19549533
Nat Commun. 2016 Nov 22;7:13363
pubmed: 27874859
J Vasc Res. 2013;50(6):445-57
pubmed: 24107797
Nature. 2016 Feb 11;530(7589):184-9
pubmed: 26840489
Aging Cell. 2018 Apr;17(2):
pubmed: 29405550
Science. 2014 May 9;344(6184):630-4
pubmed: 24797482
Am J Physiol Heart Circ Physiol. 2014 Dec 15;307(12):H1754-63
pubmed: 25326534

Auteurs

Zoltan Ungvari (Z)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary. Electronic address: zoltan-ungvari@ouhsc.edu.

Stefano Tarantini (S)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Farzaneh Sorond (F)

Department of Neurology, Division of Stroke and Neurocritical Care, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Bela Merkely (B)

Heart and Vascular Center, Semmelweis University, Budapest, Hungary.

Anna Csiszar (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH